Feb. 14, 2014, 4:04 PM
- Volatile marijuana stocks have closed with big gains after the Treasury Dept. and deputy U.S. attorney general established banking regulations for licensed sellers. Notable gainers: MDBX +21.8%. MJNA +5.1%. GRNH +4.3%. AVTC +10.4%. MWIP +7.6%. HEMP +1.7%.
- The rules allow banks to do business with marijuana sellers deemed to be obeying state laws, and not running afoul of eight principles, which include selling to minors and trafficking marijuana to states where it's illegal to do so. However, banks will have to file suspicious activity reports detailing transactions made by marijuana vendors.
- The National Cannabis Industry Association calls the ruling, which comes six weeks after Colorado began legal marijuana sales, a "huge victory." But many observers think top U.S. banks will still tread cautiously.
- FINRA has issued a warning about potential marijuana stock scams.
Jan. 9, 2014, 5:25 PM
- Medical Marijuana (MJNA +4.3%) is up 25% YTD on the pink sheets as investors continue making speculative bets on pot-related plays following the start of legal marijuana sales in Colorado on Jan. 1.
- On the other hand, several peers gave back a big chunk of their recent gains today: GRNH -52.4%. AVTC -15.8%. MDBX -18.6%. HEMP -24.1%. MWIP -21.9%.
- But GW Pharmaceuticals (GWPH +23.5%), a more established name that yesterday priced a 2.4M-share follow-on offering at $36, went in the other direction.
- With demand outstripping expectations, Colorado is (for now) arguably seeing the marijuana equivalent of the 1970s oil crisis: Long lines, shortages, rationing, and soaring prices have become the norm for licensed dispensaries.
- Words of caution from seasoned investors about putting money into pot plays are easy to find. Fund manager Frank Igarra: "There might be one or two that survive, but having seen crazes like this, people have been burned by them a lot. The average investor should think twice."
- FINRA issued a warning in August about potential marijuana stock scams.
Apr. 30, 2013, 11:01 AMMedical Marijuana (MJNA.PK +41.1%) surges after issuing a shareholder update and letter to address what it calls "recent blog articles" attacking the company. MJNA provides a lengthy defense of the CannaVest (CANV.OB) deal, recently the subject of sharp criticism from SA contributor Alan Brochstein, and says it will provide details about the transaction in its Q1 filings, due to arrive by May 15. Also, chairman/COO Michelle Sides insists she hasn't sold any shares in the company. Update: Brochstein defends himself in an Instablog. | 24 Comments
Apr. 25, 2013, 2:25 PMMedical Marijuana (MJNA.PK -13%) dives after SA contributor Alan Brochstein takes aim at the company's financials once more (previous). Brochstein points out $4.5M of MJNA's Q4 sales came from an installment payment related to a $35M deal with CannaVest (CANV.OB) signed at the end of the quarter, and that CannaVest can make deal payments with its (very illiquid) stock. He also observes MJNA's Q4 sales were revised to $4.69M from a prior $5.19M (and before that, $5.1M) in its recently updated annual report. | 10 Comments
Apr. 11, 2013, 10:36 AMMedical Marijuana (MJNA.PK +17.2%) rallies after reporting Q1 gross revenue of $8.45M (+66% Q/Q and +377% Y/Y) and net income of $5.52M. The company adds it plans to deliver a 24-month audit history of its financials by the end of Q2, and asserts it has "positioned itself to become fully reporting" with the SEC once the audit history is complete. MJNA plans to reports its audited Q1 financials by May 15. (PR) | 10 Comments
Mar. 20, 2013, 11:20 AMMedical Marijuana (MJNA.PK +6.3%) trades higher after announcing it will begin selling its products and services in Europe, Canada, and the Caribbean. The company adds it plans to invest in local manufacturers and distributors, and hopes to bring over-the-counter products to the aforementioned markets. (PR) | 15 Comments
Mar. 5, 2013, 11:00 AM
Feb. 21, 2013, 12:23 PMVolatile Medical Marijuana (MJNA.PK -20.4%) falls to $0.23 on the pink sheets after SA authors Ashraf Eassa and Panoplos offer bearish takes. Panoplos notes that while MJNA recently valued an inventory sale/licensing deal with CannaVEST (FCLS.OB) at $35M, based on an assigned value of $5 for the CannaVEST shares issued to MJNA, the actual value of the shares could be much lower. Especially since CannaVEST recently disclosed it has "no customers," and that its sole assets consist of the items purchased in its deal with MJNA. MJNA is no stranger to double-digit swings. | 18 Comments
MJNA vs. ETF Alternatives
Medical Marijuana Inc. ("MJNA") is the first publicly held company vested in the medical marijuana and industrial hemp markets. The company is comprised of a diversified portfolio of products, services, technology and businesses solely focused on the cannabis and hemp industries. These products... More
Other News & PR